Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter E Clark

Showing results (171-180 of 239) with videos related to

Pageof 24
Sort By:
Urology Practice|May 5, 2023
Reply by AuthorsMiguel Rodriguez-Homs, Rodrigo Rodrigues Pessoa, Badrinath Konety, et al.
Urology|June 13, 2006
Phase I-II prospective dose-escalating trial of lycopene in patients with biochemical relapse of prostate cancer after definitive local therapyPeter E Clark, M Craig Hall, Lester S Borden, et al.
The Journal of Urology|July 27, 2011
Predicting the probability of 90-day survival of elderly patients with bladder cancer treated with radical cystectomyTodd M Morgan, Kirk A Keegan, Daniel A Barocas, et al.
BJU International|October 14, 2014
Renal cell cancer histological subtype distribution differs by race and sexLoren Lipworth, Alicia K Morgans, Todd L Edwards, et al.
Urologic Oncology|March 28, 2021
Diagnostic renal mass biopsy is associated with individual categories of PADUA and RENAL nephrometry scores: Analysis of diagnostic and concordance rates with surgical resectionRicardo B Fonseca, Melissa M Straub Hogan, Meghan E Kapp, et al.
Urology Practice|May 5, 2023
Association of Surgical Approach and Urinary Diversion in Radical Cystectomy for Bladder Cancer With Costs and Readmission: Results From a Large Private Health Insurance CohortMiguel Rodriguez-Homs, Rodrigo Rodrigues Pessoa, Badrinath Konety, et al.
BJU International|September 11, 2012
ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinomaSamuel D Kaffenberger, Todd M Morgan, Kelly L Stratton, et al.
Translational Andrology and Urology|March 14, 2023
Prognostic value of galectin-1 and galectin-3 expression in localized urothelial bladder cancerJason Zhu, Chad Livasy, Erin E Donahue, et al.
Urologic Oncology|December 3, 2014
Statin use is associated with improved survival in patients undergoing surgery for renal cell carcinomaSamuel D Kaffenberger, Opal Lin-Tsai, Kelly L Stratton, et al.
BJU International|October 31, 2009
Open renal biopsy: comorbidities and complications in a contemporary seriesAndrew A Stec, Kelly L Stratton, Melissa R Kaufman, et al.
Pageof 24

Showing results (171-180 of 239) with videos related to

Sort By:
Pageof 24
Urology Practice|May 5, 2023
Reply by AuthorsMiguel Rodriguez-Homs, Rodrigo Rodrigues Pessoa, Badrinath Konety, et al.
Urology|June 13, 2006
Phase I-II prospective dose-escalating trial of lycopene in patients with biochemical relapse of prostate cancer after definitive local therapyPeter E Clark, M Craig Hall, Lester S Borden, et al.
The Journal of Urology|July 27, 2011
Predicting the probability of 90-day survival of elderly patients with bladder cancer treated with radical cystectomyTodd M Morgan, Kirk A Keegan, Daniel A Barocas, et al.
BJU International|October 14, 2014
Renal cell cancer histological subtype distribution differs by race and sexLoren Lipworth, Alicia K Morgans, Todd L Edwards, et al.
Urologic Oncology|March 28, 2021
Diagnostic renal mass biopsy is associated with individual categories of PADUA and RENAL nephrometry scores: Analysis of diagnostic and concordance rates with surgical resectionRicardo B Fonseca, Melissa M Straub Hogan, Meghan E Kapp, et al.
Urology Practice|May 5, 2023
Association of Surgical Approach and Urinary Diversion in Radical Cystectomy for Bladder Cancer With Costs and Readmission: Results From a Large Private Health Insurance CohortMiguel Rodriguez-Homs, Rodrigo Rodrigues Pessoa, Badrinath Konety, et al.
BJU International|September 11, 2012
ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinomaSamuel D Kaffenberger, Todd M Morgan, Kelly L Stratton, et al.
Translational Andrology and Urology|March 14, 2023
Prognostic value of galectin-1 and galectin-3 expression in localized urothelial bladder cancerJason Zhu, Chad Livasy, Erin E Donahue, et al.
Urologic Oncology|December 3, 2014
Statin use is associated with improved survival in patients undergoing surgery for renal cell carcinomaSamuel D Kaffenberger, Opal Lin-Tsai, Kelly L Stratton, et al.
BJU International|October 31, 2009
Open renal biopsy: comorbidities and complications in a contemporary seriesAndrew A Stec, Kelly L Stratton, Melissa R Kaufman, et al.
Pageof 24